Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Bone Marrow Transplantation Market Size And Revenue Outlook Through 2030
The bone marrow transplantation market size has demonstrated strong growth in recent years. This market is set to expand from $12.11 billion in 2025 to $12.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.1%. The expansion witnessed historically can be attributed to the increasing prevalence of leukemia and lymphoma, growing recognition of bone marrow transplantation, progress in transplantation techniques, the growth of hospital and clinical infrastructure, and the availability of donor registries.
The bone marrow transplantation market size is projected to exhibit robust growth in the coming years. Its valuation is predicted to reach $15.96 billion by 2030, progressing at a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this anticipated growth include novel stem cell technologies, the incorporation of AI in matching patients, the broader application of precision medicine, advancements in supportive therapies following transplantation, and the development of healthcare infrastructure in emerging economies. Key trends expected during this period involve tailored conditioning regimens, refinement of stem cell sources, advancements in post-transplant care, broader donor matching and registry initiatives, and the adoption of less invasive harvesting methods.
Get A Free Sample Report With In-Depth Market Insights:
Bone Marrow Transplantation Market Industry Drivers: What’s Behind The Revenue Growth?
Increased clinical trials in cell therapy are anticipated to advance the expansion of bone marrow transplantation in the future. These trials are research endeavors conducted on human participants to assess how safe and effective the use of living cells is for treating illnesses or health conditions. Bone marrow transplantation is frequently employed in cell therapy clinical trials because it can supply hematopoietic stem cells, which are crucial for replacing compromised cells, addressing blood-related ailments, and investigating innovative cell-based therapies for numerous diseases. For example, in December 2024, data from the Association of the British Pharmaceutical Industry, a trade association located in the UK, indicated that the number of pharmaceutical industry trials initiated in the UK grew for the second successive year, increasing from 411 in 2022 to 426 in 2023. Consequently, the expansion of clinical trials for cell therapy is set to boost the bone marrow transplantation market.
Bone Marrow Transplantation Market Segment Landscape: Which Areas Lead Development?
The bone marrow transplantation market covered in this report is segmented –
1) By Type: Autologous Bone Marrow Transplant, Allogenic Bone Marrow Transplant
2) By Indication: Hodgkin Lymphoma, Acute Leukemia, Multiple Myelomas, Solid Tumors, Non-Hodgkin Lymphoma, Other Indications
3) By End-Users: Hospitals, Multispecialty Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Autologous Bone Marrow Transplant: Peripheral Blood Stem Cell Transplant, Bone Marrow Harvesting And Storage, Conditioning Regimens, Post-Transplant Care
2) By Allogenic Bone Marrow Transplant: Matched Sibling Donor Transplant, Matched Unrelated Donor Transplant, Haploidentical Transplant, Cord Blood Transplant, Conditioning Regimens, Post-Transplant Care
#Bone Marrow Transplantation Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the bone marrow transplantation industry are embracing a strategic partnerships approach to improve access to advanced technologies, broaden available treatment options, and deliver comprehensive transplant solutions. Such partnerships involve companies utilizing each other’s strengths and resources to achieve shared benefits and success. For example, in August 2023, Ossium Health, a US-based bioengineering company, formed an alliance with Be the Match BioTherapies, a US-based provider of cell and gene therapy solutions. Through this partnership, they aim to boost bone marrow transplant accessibility and treatment efficiency. This collaboration significantly enhances Ossium’s capacity to cater to patients on a larger scale, simultaneously allowing NMDP or Be The Match to extend a vital supply of bone marrow to a broader spectrum of patients requiring life-saving treatments.
Bone Marrow Transplantation Market Industry Leaders And Competitive Landscape
Major companies operating in the bone marrow transplantation market are Merck Millipore Corporation, STEMCELL Technologies Inc., HemaCare Corporation, AllCells LLC, Lonza Group Ltd., Conversant Bio Company, Lifeline Cell Technology LLC, Mesoblast Ltd., PromoCell GmbH, ATCC Inc. (American Type Culture Collection), ReachBio LLC, Gamida Cell Ltd., Abbott Laboratories Inc., Allogene Therapeutics Inc., Amgen Inc., Angiocrine Biosciences Corp., Astellas Pharma Inc., Atara Biotherapeutics Inc., Bluebird Bio Inc., Cellectis S.A., Celyad SA, Erythrocyte Regeneration and Clinical Therapeutics Inc., Gammacell AB, Gilead Sciences Inc., Graphite Bio Inc., Incyte Corporation, Intellia Therapeutics Inc., Legend Biotech Corporation, Magenta Therapeutics Inc., Novartis AG
View The Full Bone Marrow Transplantation Market Report:
Bone Marrow Transplantation Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the bone marrow transplantation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global bone marrow transplantation market report forecast period. The regions covered in the bone marrow transplantation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model